Abstract
Bone morphogenetic proteins (BMPs) are involved in diverse biological processes, including cell proliferation, differentiation and apoptosis. Results from the MTT assay revealed that BMP-2 significantly inhibited the proliferation of MDA-MB‑231 and MCF-7 breast cancer cells. The flow cytometric analysis demonstrated that BMP-2 caused G1 arrest and promoted apoptosis. An increase in p21 and cleaved caspase-3 in the two cell lines was detected by western blot analysis, which may be responsible for the suppression of cancer cell proliferation caused by BMP-2. BMP-2 protected MDA-MB-231 and MCF-7 cells from generating xenograft tumors in nude mice. Thus, BMP-2 may be considered as an inhibitor of breast cancer at the early stages of disease.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Apoptosis / drug effects
-
Bone Morphogenetic Protein 2 / pharmacology*
-
Bone Morphogenetic Protein 2 / therapeutic use
-
Bone Morphogenetic Protein Receptors, Type I / genetics
-
Bone Morphogenetic Protein Receptors, Type I / metabolism
-
Bone Morphogenetic Protein Receptors, Type II / genetics
-
Bone Morphogenetic Protein Receptors, Type II / metabolism
-
Breast Neoplasms / drug therapy
-
Breast Neoplasms / metabolism
-
Breast Neoplasms / pathology
-
Caspase 3 / metabolism
-
Cell Line, Tumor
-
Cell Proliferation / drug effects*
-
Female
-
G1 Phase Cell Cycle Checkpoints / drug effects
-
Humans
-
Mice
-
Mice, Nude
-
Smad4 Protein / genetics
-
Smad4 Protein / metabolism
-
Transplantation, Heterologous
Substances
-
Bone Morphogenetic Protein 2
-
Smad4 Protein
-
BMPR1A protein, human
-
BMPR1B protein, human
-
BMPR2 protein, human
-
Bone Morphogenetic Protein Receptors, Type I
-
Bone Morphogenetic Protein Receptors, Type II
-
Caspase 3